[HIV therapy of the next generation. Modern active drugs for long-term treatment].
D019380:Anti-HIV Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D000069454:Darunavir; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D015507:Drugs, Investigational / Q000009:adverse effects / Q000627:therapeutic use*; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D008134:Long-Term Care; D009570:Nitriles / Q000009:adverse effects / Q000627:therapeutic use; D011724:Pyridazines / Q000627:therapeutic use; D011743:Pyrimidines / Q000009:adverse effects / Q000627:therapeutic use; D000068696:Rilpivirine; D013449:Sulfonamides / Q000009:adverse effects / Q000627:therapeutic use
D019380:Anti-HIV Agents; D015507:Drugs, Investigational; D009570:Nitriles; D011724:Pyridazines; D011743:Pyrimidines; D013449:Sulfonamides; C451734:etravirine; D000068696:Rilpivirine; D000069454:Darunavir